| Dynamic impact of uncertainty on R&D cooperation formation and research performance: Evidence from the bio-pharmaceutical industry T Banerjee, R Siebert Research Policy 46 (7), 1255-1271, 2017 | 62 | 2017 |
| U.S. county level analysis to determine If social distancing slowed the spread of COVID-19 T Banerjee, A Nayak Pan American Journal of Public Health, 2020 | 37 | 2020 |
| A county-level study of the effects of state-mandated COVID-19 lockdowns on urban and rural restaurant visits using consumers’ cell phone geo-location data T Banerjee, A Nayak, HY Zhao Journal of Public Health, 1-10, 2021 | 27 | 2021 |
| Comparing domestic and cross-border mergers and acquisitions in the pharmaceutical industry T Banerjee, A Nayak Atlantic Economic Journal 43, 489-499, 2015 | 25 | 2015 |
| Believe it or not: Health education works T Banerjee, A Nayak Obesity Research & Clinical Practice 12 (1), 116-124, 2018 | 15 | 2018 |
| The impact of R&D cooperations and mergers in pharmaceuticals on research activities and drugs offered on the market T Banerjee, R Siebert Southern Economic Journal 84 (1), 202-228, 2017 | 12 | 2017 |
| Multinational investments and product sophistication T Banerjee, A Nayak Economics letters 161, 157-163, 2017 | 8 | 2017 |
| Association of authorized generic marketing with prescription drug spending on antidepressants from 2000 to 2011 N Cheng, T Banerjee, J Qian, RA Hansen Journal of the American Pharmacists Association 57 (3), 341-348, 2017 | 7 | 2017 |
| Aspects of research and development contract terms in the bio/pharmaceutical sector T Banerjee the economics of medical technology, 1-33, 2012 | 7 | 2012 |
| Causal connections between socioeconomic disparities and COVID-19 in the USA T Banerjee, A Paul, V Srikanth, I Strümke Scientific Reports 12 (1), 15827, 2022 | 5 | 2022 |
| A neurobehavioral study on the efficacy of price interventions in promoting healthy food choices among low socioeconomic families T Banerjee, V Chattaraman, H Zou, G Deshpande Scientific Reports 10 (1), 15435, 2020 | 5 | 2020 |
| Pharmaceutical regulation and innovative performance: A decision‐theoretic model T Banerjee, S Martin Managerial and Decision Economics 36 (3), 177-190, 2015 | 4 | 2015 |
| Socioeconomic disparities and COVID-19: the causal connections T Banerjee, A Paul, V Srikanth, I Strümke arXiv preprint arXiv:2201.07026, 2022 | 3 | 2022 |
| Is it the wage premium that targets worker turnovers? T Banerjee, A Nayak Applied Economics Letters 25 (11), 796-799, 2018 | 3 | 2018 |
| Effective governance, female educational attainment, leadership and healthcare outcomes T Banerjee, P Bobrowski, B Friedman Theoretical Economics Letters 7 (5), 1223-1232, 2017 | 3 | 2017 |
| The Impact of R&D Cooperations on Drug Variety Offered on the Market. Evidence from the Pharmaceutical Industry T Banerjee, R Siebert CESifo Working Paper Series, 2014 | 3 | 2014 |
| Competition Strategy and Geographical Proximity of Contract Research Organizations T Banerjee, A Nayak Theoretical Economics Letters 7 (5), 1413-1422, 2017 | 2 | 2017 |
| Effects of Trade Related Intellectual Property Rights on the research and development expenditure of Indian pharmaceutical industry T Banerjee, A Nayak Journal of Pharmaceutical Health Services Research 5 (2), 89-94, 2014 | 2 | 2014 |
| Effect of research and development outsourcing on new drug approvals in the pharmaceutical industry T Banerjee, A Nayak Journal of Pharmaceutical Health Services Research 4 (1), 51-56, 2013 | 2 | 2013 |
| Beneficiation practices in the Sukinda valley area chromite deposits TH Banerjee, AK Sengupta, AT Sutaone, CS Gundewar | 2 | 2006 |
